2,5-Dioxopyrrolidin-1-yl 2,5,8,11,14,17,20,23-octaoxahexacosan-26-oate, 98%, 1g

tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate, 97%, 250mg

1,8-Dibromo-3-(methoxymethoxy)naphthalene, 98%, 100mg

2-(DIPHENYLMETHYL)-2,6-DIAZASPIRO[3.4]OCTANE, 95.0%, 10g

1-(3-Fluoro-2-nitrophenyl)piperidin-4-amine hydrochloride, 95.0%, 1g

5-Methyl-4-nitro-3-isoxazolecarboxylic acid 10% in THF, 95.0%, 1g

(4-Hydroxy-phenyl)-piperazin-1-yl-methanone, 10g

4-Hydroxybenzylamine, 97.0%, 1g

2-(4-Ethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

Sodium succinate dibasic hexahydrate, 99.0%, 500g

Ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazole-5-carboxylate, 95.0%, 100g

Neobavaisoflavone>97.0%(HPLC)25mg

C-[1-((E)-4-Phenyl-but-3-enyl)-piperidin-3-yl]-methylamine hydrochloride, 95.0%, 100mg